We designed and synthesized novel PPAR delta antagonists based on the crystal structure of the PPAR delta full agonist TIPP-204 bound to the PPAR delta ligand-binding domain, in combination with our nuclear receptor helix 12 folding modification hypothesis. Representative compound 3a exhibits PPAR delta-preferential antagonistic activity. (C) 2009 Elsevier Ltd. All rights reserved.
We designed and synthesized novel PPAR delta antagonists based on the crystal structure of the PPAR delta full agonist TIPP-204 bound to the PPAR delta ligand-binding domain, in combination with our nuclear receptor helix 12 folding modification hypothesis. Representative compound 3a exhibits PPAR delta-preferential antagonistic activity. (C) 2009 Elsevier Ltd. All rights reserved.